Corpus Intelligence IC Memo — ST. LOUIS CHILDRENS HOSPITAL 2026-04-26 03:51 UTC
IC Memo — ST. LOUIS CHILDRENS HOSPITAL
Investment Committee Memorandum | MO | 445 beds | Grade C | EBITDA uplift $65.2M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ST. LOUIS CHILDRENS HOSPITAL

CCN 263301 | ST. LOUIS, MO | 445 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ST. LOUIS CHILDRENS HOSPITAL is a 445-bed suburban community hospital in ST. LOUIS, MO with $886.1M in net patient revenue and a 6.4% operating margin. The hospital serves a payer mix of 0.5% Medicare, 7.0% Medicaid, and 92.6% commercial.

Thesis: Platform Growth. Our ML models identify $65.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 6.4% to 13.8% (+736bps).

Net Revenue HCRIS$886.1M
Current EBITDA COMPUTED$56.6M
Operating Margin COMPUTED6.4%
Occupancy HCRIS65.9%
Revenue / Bed COMPUTED$2.0M
Net-to-Gross HCRIS47.0%
Distress Probability ML45.9%

2. Market Context & Competitive Position

138
MO Hospitals
-6.2%
State Median Margin
28
Comparable Hospitals

MO has 138 Medicare-certified hospitals with a median operating margin of -6.2%. The target's margin of 6.4% places it above the state median. Among 28 size-comparable peers (222-890 beds), the median margin is -3.6%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (222-890), prioritizing same-state peers. 28 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ST. LOUIS CHILDRENS HOSPITAL (Target)MO445$886.1M6.4%
CHILDRENS MERCY HOSPITALMO328$1.44B30.5%
MERCY HOSPITAL - ST. LOUISMO815$1.39B13.5%
COXHEALTHMO791$1.38B-7.6%
UNIV OF MISSOURI HEALTH CAREMO521$1.36B-2.0%
MERCY HOSPITAL SPRINGFIELDMO617$1.05B6.1%
SAINT LUKES HOSPITAL OF KANSASMO466$883.5M-12.4%
SSM HEALTH ST. MARYS HOSPITAL MO501$792.8M-0.0%
SSM SAINT LOUIS UNIVERSITY HOSMO317$772.2M-6.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $65.2M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$18.6M+210bp18mo
Cost to Collect4.5%2.5%$17.7M+200bp12mo
Denial Rate Reduction12.0%6.5%$17.5M+198bp12mo
A/R Days Reduction5200.0%3800.0%$10.8M+122bp9mo
Clean Claim Rate88.0%96.0%$567K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$18.6M
Cost to Collect
$17.7M
Denial Rate Reduction
$17.5M
A/R Days Reduction
$10.8M
Clean Claim Rate
$567K
Total EBITDA Uplift$65.2M
Current EBITDA$56.6M
+ RCM Uplift+$65.2M
Pro Forma EBITDA$121.9M
Current Margin6.4%
Pro Forma Margin13.8%
WC Released (1x)$34.0M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$87.1M$1.03B11.77x63.7%
Base (11x exit)10.0x11.0x$87.1M$1.16B13.28x67.7%
Bull Case9.0x11.0x$78.4M$1.40B17.86x78.0%
Bull (12x exit)9.0x12.0x$78.4M$1.55B19.77x81.6%
Bear Case11.0x10.0x$95.8M$671.4M7.01x47.6%
Bear (11x exit)11.0x11.0x$95.8M$769.7M8.03x51.7%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 28 hospitals with 222-890 beds
  • Same-state prioritization (n=29)
  • Comp margins: P25=-12.4% / P50=-3.6% / P75=3.6%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.